Literature DB >> 33853351

Association Between Genetic Variation in Blood Pressure and Increased Lifetime Risk of Peripheral Artery Disease.

Michael G Levin1,2,3, Derek Klarin4,5, Venexia M Walker6, Dipender Gill7,8,9,10,11, Julie Lynch12,13, Jacklyn N Hellwege14,15, Jacob M Keaton16,17, Kyung M Lee3,13,18,19, Themistocles L Assimes20,21,22, Pradeep Natarajan23,24,25,26, Adriana M Hung27, Todd L Edwards28, Daniel J Rader2,29,30, J Michael Gaziano31,26, Neil M Davies6,32, Philip S Tsao20,21,22, Kyong-Mi Chang2, Benjamin F Voight29,30,33,3, Scott M Damrauer34,3.   

Abstract

[Figure: see text].

Entities:  

Keywords:  atherosclerosis; blood pressure; coronary artery disease; peripheral artery disease; risk factors

Mesh：

Substances：

Year:  2021        PMID： 33853351      PMCID： PMC8159880          DOI： 10.1161/ATVBAHA.120.315482

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


  42 in total

Review 1.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  J Am Coll Cardiol       Date:  2017-03-21       Impact factor: 24.094

2.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Authors:  Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-03-01       Impact factor: 29.983

3.  Determinants of peripheral arterial disease in the elderly: the Rotterdam study.

Authors:  W T Meijer; D E Grobbee; M G Hunink; A Hofman; A W Hoes
Journal:  Arch Intern Med       Date:  2000-10-23

4.  Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study.

Authors:  J D Hooi; A D Kester; H E Stoffers; M M Overdijk; J W van Ree; J A Knottnerus
Journal:  Am J Epidemiol       Date:  2001-04-01       Impact factor: 4.897

5.  Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study.

Authors:  D Bainton; P Sweetnam; I Baker; P Elwood
Journal:  Br Heart J       Date:  1994-08

6.  Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention.

Authors:  Dominic P J Howard; Amitava Banerjee; Jack F Fairhead; Linda Hands; Louise E Silver; Peter M Rothwell
Journal:  Circulation       Date:  2015-09-08       Impact factor: 29.690

7.  The MR-Base platform supports systematic causal inference across the human phenome.

Authors:  Gibran Hemani; Jie Zheng; Benjamin Elsworth; Tom R Gaunt; Philip C Haycock; Kaitlin H Wade; Valeriia Haberland; Denis Baird; Charles Laurin; Stephen Burgess; Jack Bowden; Ryan Langdon; Vanessa Y Tan; James Yarmolinsky; Hashem A Shihab; Nicholas J Timpson; David M Evans; Caroline Relton; Richard M Martin; George Davey Smith
Journal:  Elife       Date:  2018-05-30       Impact factor: 8.140

8.  Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects.

Authors:  Dipender Gill; Marios K Georgakis; Fotios Koskeridis; Lan Jiang; Qiping Feng; Wei-Qi Wei; Evropi Theodoratou; Paul Elliott; Joshua C Denny; Rainer Malik; Evangelos Evangelou; Abbas Dehghan; Martin Dichgans; Ioanna Tzoulaki
Journal:  Circulation       Date:  2019-06-25       Impact factor: 29.690

9.  An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.

Authors:  Eleanor Sanderson; George Davey Smith; Frank Windmeijer; Jack Bowden
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

10.  Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study.

Authors:  Michael G Levin; Derek Klarin; Themistocles L Assimes; Matthew S Freiberg; Erik Ingelsson; Julie Lynch; Pradeep Natarajan; Christopher O'Donnell; Daniel J Rader; Philip S Tsao; Kyong-Mi Chang; Benjamin F Voight; Scott M Damrauer
Journal:  JAMA Netw Open       Date:  2021-01-04
View more
  6 in total

1.  Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.

Authors:  Jie V Zhao; Fangchao Liu; C Mary Schooling; Jianxin Li; Dongfeng Gu; Xiangfeng Lu
Journal:  Diabetologia       Date:  2022-01-26       Impact factor: 10.122

2.  Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse.

Authors:  Vanessa Troiani; Richard C Crist; Glenn A Doyle; Thomas N Ferraro; Donielle Beiler; Stephanie Ranck; Kortney McBryan; Margaret A Jarvis; Jordan S Barbour; John J Han; Ryan J Ness; Wade H Berrettini; Janet D Robishaw
Journal:  BMC Med Genomics       Date:  2021-10-26       Impact factor: 3.063

3.  Causal Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Peripheral Artery Disease: A Mendelian Randomization Approach.

Authors:  Anna G Hoek; Sabine van Oort; Petra J M Elders; Joline W J Beulens
Journal:  J Am Heart Assoc       Date:  2022-08-05       Impact factor: 6.106

Review 4.  Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease.

Authors:  Pavel Poredoš; Mišo Šabovič; Mojca Božič Mijovski; Jovana Nikolajević; Pier Luigi Antignani; Kosmas I Paraskevas; Dimitri P Mikhailidis; Aleš Blinc
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

5.  Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.

Authors:  Michael G Levin; Verena Zuber; Venexia M Walker; Derek Klarin; Julie Lynch; Rainer Malik; Aaron W Aday; Leonardo Bottolo; Aruna D Pradhan; Martin Dichgans; Kyong-Mi Chang; Daniel J Rader; Philip S Tsao; Benjamin F Voight; Dipender Gill; Stephen Burgess; Scott M Damrauer
Journal:  Circulation       Date:  2021-06-18       Impact factor: 29.690

6.  Effect of Peptidylarginine Deiminase 4 on Endothelial Progenitor Cell Function in Peripheral Arterial Disease.

Authors:  Jialin Pan; Wenqin Liu; Ye Chen; Chi Zhang; Cong Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-26       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.